FIELD: medicine.
SUBSTANCE: invention is intended for the early diagnosis of type III Oddi's sphincter dysfunction in patients operated due to cholelithiasis. The level of digestive tract neuropeptides and nitric oxide is additionally determined when entering the surgical department and at concentrations of neuropeptide-dilators below 0.5 ng/ml, neuropeptide constrictors above 1.0 ng/ml, nitric oxide below 9.75 μmol/l, type III Oddi's sphincter dysfunction is diagnosed.
EFFECT: method allows to increase the efficiency of early diagnosis and timely conduct preventive and curative measures and dispensary observation of this category of patients.
3 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTIOM OF STRUCTURE OF COMMON BILE DUCT AND HEPATICOPANCREATIC AMPULLA STENOSIS IN PATIENTS AFTER CHOLECYSTECTOMY DUE TO CHOLELITHIASIS | 2016 |
|
RU2635962C1 |
DIAGNOSTIC TECHNIQUE FOR FUNCTION-TYPE ODDI'S SPHINCTER DYSSYNERGIA FOLLOWING CHOLECYSTECTOMY | 2009 |
|
RU2416802C1 |
METHOD FOR PREDICTION OF DEVELOPING FUNCTION-TYPE ODDI'S SPHINCTER DYSSYNERGIA FOLLOWING CHOLECYSTECTOMY | 2009 |
|
RU2414712C1 |
METHOD OF ENDOSCOPIC PAPILLOSPHYNCTEROTOMY | 2011 |
|
RU2463975C1 |
METHOD FOR ENDOSCOPIC SPHINCTER-PRESERVING ATYPICAL PAPILLOTOMY IN CHOLEDOCHOLITHIASIS | 2021 |
|
RU2771260C1 |
METHOD FOR APPLYING PAPILLOSPHINCTEROPLASTY | 1999 |
|
RU2179412C2 |
METHOD OF CORRECTING PSYCHOVEGETATIVE DISORDERS IN PATIENTS WITH CHOLELITHIASIS AFTER CHOLECYSTECTOMY | 2008 |
|
RU2401659C2 |
METHOD FOR EVALUATING FUNCTIONAL STATE OF BILIARY SYSTEM IN PATIENTS AFTER CHOLECYSTECTOMY | 2005 |
|
RU2283032C1 |
METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF ODDI SPHINCTER DYSFUNCTION | 2004 |
|
RU2245102C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF HEPATORENAL SYNDROME IN PATIENTS WITH PORTAL HYPERTENSION OF CIRRHOTIC ORIGIN | 2017 |
|
RU2675826C1 |
Authors
Dates
2017-08-29—Published
2016-09-26—Filed